Home › Macular Degeneration › North Carolina › Hickory
Macular Degeneration clinical trials in Hickory, NC
3 studies for Macular Degeneration are looking for participants at sites in and around Hickory (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
RecruitingPhase 2/3
- Graystone Eye, Hickory
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
RecruitingPhase 3
- Graystone Eye, Hickory
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
RecruitingPhase 2/3
- Graystone Eye, Hickory
About Macular Degeneration
Macular degeneration, or age-related macular degeneration (AMD), causes vision loss in older adults. Learn about the types and what can help.
More about Macular Degeneration on MedlinePlus
Macular Degeneration trials in other cities
- Dallas, TX13 studies
- Erie, PA10 studies
- The Woodlands, TX9 studies
- Reno, NV8 studies
- Sacramento, CA8 studies
- Hagerstown, MD8 studies
- Cleveland, OH7 studies
- Fort Worth, TX7 studies
- Houston, TX7 studies
- Carmel, IN7 studies
- Salt Lake City, UT7 studies
- Austin, TX7 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.